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Abstract
Adverse events in pregnancy may ‘programme’ offspring for the later development of cardiovascular disease and
hypertension. Previously, using a rodent model of programmed hypertension we have demonstrated the role of the renin-
angiotensin system in this process. More recently we showed that a maternal low protein diet resulted in undermethylation
of the At1b angiotensin receptor promoter and the early overexpression of this gene in the adrenal of offspring. Here, we
investigate the hypothesis that maternal glucocorticoid modulates this effect on fetal DNA methylation and gene
expression. We investigated whether treatment of rat dams with the 11b-hydroxylase inhibitor metyrapone, could prevent
the epigenetic and gene expression changes we observed. Offspring of mothers subjected to a low protein diet in
pregnancy showed reduced adrenal Agtr1b methylation and increased adrenal gene expression as we observed previously.
Treatment of mothers with metyrapone for the first 14 days of pregnancy reversed these changes and prevented the
appearance of hypertension in the offspring at 4 weeks of age. As a control for non-specific effects of programmed
hypertension we studied offspring of mothers treated with dexamethasone from day 15 of pregnancy and showed that,
whilst they had raised blood pressure, they failed to show any evidence of Agtr1b methylation or increase in gene
expression. We conclude that maternal glucocorticoid in early pregnancy may induce changes in methylation and
expression of the Agtr1b gene as these are clearly reversed by an 11 beta-hydroxylase inhibitor. However in later pregnancy
a converse effect with dexamethasone could not be demonstrated and this may reflect either an alternative mechanism of
this glucocorticoid or a stage-specific influence.
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Introduction
It is recognised that the onset and development of disease in
adult life is influenced by the quantity and quality of nutrition
during the fetal period [1–5]. Epidemiological studies in developed
and developing countries have strongly suggested that the
intrauterine environment plays a role in determining risk of adult
disease. Many cohort studies indicate that lower weight at birth,
followed by rapid catch-up growth in childhood, is associated with
risk of metabolic syndrome and cardiovascular disease in
adulthood [6–11]. It has been proposed that maternal undernu-
trition may ‘‘programme’’ long-term changes in gene expression in
the fetus, resulting in cardiovascular and metabolic abnormalities
in later life. This epidemiological data is strongly supported by
evidence from animal models [12–15]. Our laboratory has
established a rat model of programmed hypertension and
metabolic syndrome, in which the feeding of a low protein diet
during pregnancy results in the development of a programmed
phenotype in the offspring [16,17].
There is currently considerable interest in the potential for
nutritionally-mediated changes to epigenetic markers in the fetal
genome to drive the development of programmed cardiovascular
disease. A range of studies using the model of protein restriction
during rat pregnancy have suggested that maternal undernutrition
leads to reduced methylation and hence increased gene expression
of important metabolic and physiological regulators in the
offspring [18–20]. Heijmans et al (2008) have reported similar
hypomethylation of the imprinted IGF2 gene in human subjects
exposed to famine during fetal development [21].
We recently demonstrated that maternal protein undernutrition
in pregnancy leading to the development of hypertension in the
offspring was associated with reduced methylation and increased
expression of the At1b angiotensin receptor gene (Agtr1b)
expression in the rat adrenal gland [22]. Offspring from
pregnancies in which the mother had been subjected to an
isocaloric low protein diet throughout pregnancy were found to
have a number of alterations in expression of components of the
renin-angiotensin system in several tissues [23,24]. The earliest
significant changes were found in the expression of the AT1b and
AT2 angiotensin receptor in the adrenal [22]. This finding is
consistent with increased adrenal responsiveness to angiotensin
[25] and observations that the development of hypertension can be
prevented by administration of ACE inhibitors or AT1 antagonists
in early life [23,26]. In addition, we were able to show that the low
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protein diet offspring had reduced methylation of CpG sites in the
proximal promoter of the Agtr1b implying an epigenetic mecha-
nism may, at least in part, explain this effect [22].
The maternal low protein diet model of programming is a
widely used model, but is not unique. Other causes of maternal
stress can result in similar long term consequences and this has led
to the proposal that stress-related over-activity of the maternal
pituitary-adrenal axis in pregnancy results in over-exposure of the
fetus to maternal glucocorticoids and that this provides a common
mechanism that leads to the changes in gene expression and
ultimately the long-term pathological consequences associated
with programming. In support of this hypothesis, administration of
dexamethasone in pregnancy also has similar long term cardio-
vascular consequences [27,28].
In this study we wished to test the glucocorticoid hypothesis
using Agtr1b expression and epigenetic changes as molecular end
points. The most direct test of the hypothesis is to expose pregnant
animals receiving a low protein diet to the 11 b-hydroxylase
inhibitor, metyrapone which blocks the last steps of corticosterone
synthesis in the rat [29]. We have previously shown that this
protocol normalizes the blood pressure of the resulting offspring of
protein restricted rats, strongly suggesting that steroids play a key
role in mediating the programming effects of undernutrition
[24,27]. If glucocorticoids are central to the low protein effects,
metyrapone should block the early change in gene expression. As
in our previous reports this study targeted the blockade to the first
14 days of gestation, as prolonged use of this drug in pregnancy
can inhibit lung maturation in the fetus. For comparison with
another model of programmed hypertension we studied offspring
of mothers treated with dexamethasone during pregnancy. In this
second experiment, the final week of gestation was targeted for
intervention as this has been previously shown to be the period of
maximal sensitivity of rat fetal development to glucocorticoid
exposure [27,30]. In all cases offspring were studied postnatally for
alterations in Agtr1b expression and DNA methylation at 1 week of
life and at 4 weeks for blood pressure.
Results
Metyrapone Study
8 litters from mothers fed (a) a control diet, (b) a low protein
diet or (c) a low protein diet with metyrapone administered for
the first fourteen days of pregnancy were studied. Consistent with
our previous reports [16,24] neither low protein feeding, nor
treatment with metyrapone had any significant impact upon
maternal weight gain in pregnancy, reproductive outcome or
birth weights of the offspring (Table 1). Offspring were weaned
onto standard laboratory chow and blood pressure was measured
at four weeks of age. Blood pressure is unlikely to be altered at
earlier time points and is technically more difficult to measure.
Figure 1a shows that both males and females subjected to low
protein during fetal life had significantly greater systolic blood
pressure, whereas animals whose mothers were treated with
metyrapone maintained control levels of blood pressure. A 2 way
ANOVA for sex and maternal treatment was performed and this
showed no effect of sex (F = 1.737, p = 0.146), an effect of
treatment (F = 4.837, p = 0.013) and no interaction of sex and
treatment (F = 0.375, p = 0.689).
Adrenal glands were harvested from 1 week old animals and
used to make cDNA and genomic DNA. This time point was
chosen as previous work had shown that RNA expression changes
were statistically significant at this time point (22), whereas at later
time points changes in expression of some genes were likely to be
secondary to development of hypertension. If changes in gene
expression at 1 week were related to DNA methylation we would
expect to identify such methylation changes in adrenals at this age
also. Real-time PCR was performed on these samples using Agtr1b
and 18S RNA primers. As we have shown previously, Agtr1b
mRNA expression was significantly greater in MLP adrenal
offspring, but administration of metyrapone completely prevented
this overexpression (Figure 2a).
Genomic DNA prepared from these adrenals at 1 week of age
was bisulphite converted, amplified and subcloned. Individual
clones from adrenals from 5 different animals in each treatment
group were sequenced to determine the degree of methylation of
the three CpG sites in the AT1b proximal promoter. As we
reported previously, the MLP offspring had less methylation at
these sites compared to controls (controls, 20.0%; LP, 10.8%;
p,0.05). Administration of metyrapone in early pregnancy
significantly reversed this trend though, such that methylation
levels were indistinguishable from controls and significantly
greater than the LP group (LP, 10.8%; LPM, 23.8%; p,0.05).
These changes were most clearly reflected in the methylation
status of CpG site 3 (control, 28.9%; LP, 5.4%; LPM, 40%)
(Figure 2b).
Dexamethasone Study
For comparison with a distinct model of hypertension
programmed in utero, rats were administered dexamethasone
during pregnancy. Table 2 shows the maternal response to
dexamethasone administration, which had no significant impact
upon either gestational weight gain or reproductive outcomes.
Surprisingly, at this administered dose of dexamethasone there
was no suppression of food intake and in fact the pair-fed controls
had a non-significant trend towards slightly less food consump-
tion than the treatment group over the final week of gestation.
Pups born to dexamethasone treated dams were of normal birth
weight. At four weeks of age a similar effect on blood pressure to
that observed after the MLP diet was observed and blood
pressure was influenced by dexamethasone treatment (P,0.001)
and by the interaction of sex and treatment (p = 0.049)
(Figure 1b).However no difference in adrenal Agtr1b expression
at one week of age could be identified (Figure 3a). Furthermore,
analysis of the same proximal promoter CpG sites from 9 controls
and 6 treated adrenals showed very similar degrees of
methylation (Control 26.9%; Dex treated 24.2%; not significant)
(Figure 3b).
Table 1. Maternal weight gain, food intake and reproductive
outcomes following protein restriction and metyrapone
administration over d0–14 gestation.
Maternal diet Treatment
Control
Saline LP Saline LP Metyrapone
Weight at mating (g) 24767 25366 24467
Weight at delivery (g) 383612 40268 38768
Food intake d0–7 (g/day) 29.262.6 32.461.4 30.660.9
Food intake d8–14 (g/day) 26.462.0 27.761.2 26.661.9
Food intake d15–22 (g/day) 26.562.8 23.560.7 26.062.0
Litter size (no. pups) 1261 1361 1461
Birth weight male offspring (g) 5.6060.12 5.2360.16 5.6160.25
Birth weight female offspring (g) 5.1860.14 4.9660.23 5.4060.19
Data are shown as mean 6 SEM for 8 observations per group. There were no
significant differences between the groups.
doi:10.1371/journal.pone.0009237.t001
AT1b Programming
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Discussion
In this study we have reproduced the findings reported in our
previous paper showing that at one week of postnatal life, rat
offspring that were exposed to a maternal low protein diet in utero
have increased expression of the adrenal Agtr1b and reduced
methylation of CpG residues in its proximal promoter [22]. By the
age of four weeks these animals already showed evidence of
hypertension. The novel finding we report here however is that
when the mothers receive metyrapone during the first two weeks of
pregnancy the hypertension, the increased Agtr1b expression and
the reduced DNA methylation were all normalised. The findings
of this study are, therefore, highly suggestive of the maternal
pituitary-adrenal axis playing a central role in mediating the
adverse effects of the low protein diet and this would be consistent
with widely held views [31].
Alternative explanations should be considered however. One
possibility is that metyrapone has induced a long-term effect on
adrenal development and differentiation such that 1 week old
animals are hypoadrenal and consequently protected from
developing hypertension. Though unlikely in view of the extensive
experience in the use of this drug, it is notable that the size of
adrenals did not differ in the metyrapone group (data not shown).
In the rat fetus, the adrenal exists as a distinct organ at 14 days, but
has no evidence of zonation. The Agtr1b is not expressed at this
early stage [32,33]. Consequently this data suggests that a maternal
glucocorticoid effect is able to ‘programme’ the expression of the
Agtr1b at an early, pre-zonation, stage of adrenal development.
One explanation for these observations is that activated
glucocorticoid receptor binds to the two functional GREs in the
Agtr1b [34,35] and that this process consequently impairs the laying
down of DNA methylation that would normally take place during
this phase of differentiation and development. A large number of
genes contain GREs and this might be a very detrimental process if
it applied to all glucocorticoid responsive genes in the fetus.
Therefore it seems probable that there is greater complexity and
specificity in effecting this response. Alternatively, the DNA region
around CpG site 3 in the Agtr1b forms a perfect polycomb response
element. Such elements are complex and include binding sites for
several proteins [36] and may act as transcriptional repressors or
Figure 1. Blood pressure at 4 weeks of age in offspring. A) rats fed low protein diet throughout pregnancy without (LP) or with metyrapone
over days 0–14 gestation (LPM), and B) rats treated with dexamethasone over days 15–22 gestation. Data are shown as mean 6 SEM for 8
observations per group. Two way ANOVA indicated that in the metyrapone experiment blood pressure was influenced by maternal treatment
(p = 0.006), but there was no effect of sex. In the dexamethasone study, blood pressure was influenced by dexamethasone treatment (P,0.001) and
by the interaction of sex and treatment (p = 0.049). All measurements were corrected for body weight.
doi:10.1371/journal.pone.0009237.g001
AT1b Programming
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activators of particular importance in early development [37–40].
Precisely how the DNA methylation observed at this site would
relate to polycomb activity which would normally result in specific
histone methylation marks is not clear at present.
Although confirmatory of earlier studies [24,41], the finding that
dexamethasone in the final week of gestation could elevate blood
pressure in the offspring independently of any effects upon maternal
food intake is important. Woods and colleagues have asserted that
rather than glucocorticoids mediating programming effects of
undernutrition, all effects of steroid treatment in rodent pregnancy
are related to associated reductions in food intake [31]. Our findings
refute this assertion. The selectivity of the effect is demonstrated by
our observation that dexamethasone administration does not lead to
increased Agtr1b expression or alteration of methylation. Interestingly
we also noted a strong sex-specific effect in the dexamethasone study
consistent with our previous findings [24].
The distinct characteristics of the two hypertension-inducing
treatments used in this study may reflect the different stages in
pregnancy at which each of the drugs was administered. It could
be inferred that that early glucocorticoid exposure results in Agtr1b
changes, whereas later exposure acts upon blood pressure
regulation through an independent, sexually dimorphic mecha-
nism. Experiments with prenatal protein restriction indicate that
the insult can induce hypertension at any stage of pregnancy
[16,42], but that effects are greatest if the undernutition is induced
later in gestation. Alternatively, it could be argued that
dexamethasone, in contrast to corticosterone, will not be
susceptible to conversion into inactive steroid by 11 b-hydroxy-
steroid dehydrogenase in the placenta and will almost certainly
provide a more potent glucocorticoid stimulus to the developing
adrenal than maternal corticosterone could do. Dexamethasone
lacks significant mineralocorticoid activity [43], whereas endoge-
Figure 2. Effect of Metyrapone on Agtr1b expression and DNAmethylation. (A) Gene expression in animals at 1 week of age whose mothers
received control (C) or low protein diets during pregnancy with vehicle alone (LP) or metyrapone (LPM) for the first fourteen days of pregnancy.
Results are expressed relative to the 18S ribosomal RNA and are expressed as the mean 6 SEM. The number of adrenals studied in each group is
shown below each column. * p,0.05; *** p,0.005 (B) Methylation of the three most proximal CpG sites in the Agtr1b promoter in the adrenal at 1
week of age. Each empty circle represents an unmethylated CpG site, while filled circles represent methylated sites. Each column represents a single
adrenal, the sex of which is shown above the column. Each horizontal group of three circles indicates a single sequenced clone. Differences between
groups are calculated by Chi squared. * p,0.05; ** p,0.01; *** p,0.005.
doi:10.1371/journal.pone.0009237.g002
AT1b Programming
PLoS ONE | www.plosone.org 4 February 2010 | Volume 5 | Issue 2 | e9237
nous maternal corticosterone has a potent mineralocorticoid effect
in addition to maternal aldosterone. Treatment of animals with
metyrapone inhibits both corticosterone and aldosterone synthesis,
perhaps suggesting that mineralocorticoid receptor dependent
mechanisms are important in programming AT1b gene expression
at this earlier stage of pregnancy.
In conclusion, these studies confirm our earlier observations
linking the adverse effects of fetal programming events to
epigenetic mechanisms and strongly suggest a role for maternal
glucocorticoid in this process. Epigenetic mechanisms have been
associated with the consequences of programming in several
models affecting for example the glucocorticoid receptor, PPARa
and DNA methyltransferase [18–20]. Such observations suggest a
highly plausible mechanism leading to long-term adverse conse-
quences. The major challenges now seem to be in understanding
how the prenatal insult brings about the epigenetic changes
observed and in demonstrating the causative, as opposed to
reactive role for such changes.
Table 2. Maternal weight gain, food intake and reproductive
outcomes following dexamethasone administration over d15–
22 gestation.
Control (pair fed)
Dexamethasone
treated
Weight at mating (g) 26866 26267
Weight at delivery (g) 416613 41767
Food intake d0–7 (g/day) 25.660.6 26.360.7
Food intake d8–14 (g/day) 29.160.5 29.860.6
Food intake d15–22 (g/day) 29.360.9 29.860.7
Litter size (no. pups) 1461 1561
Birth weight male offspring (g) 6.6760.24 6.6560.17
Birth weight female offspring (g) 6.4260.20 5.8860.25
Data are shown as mean 6 SEM for 8 observations per group. There were no
significant differences between the two groups.
doi:10.1371/journal.pone.0009237.t002
Figure 3. Effect of Dexamethasone on Agtr1b expression and DNA methylation. (A) Expression of the Agtr1b at one week of age in animals
whose mothers received control (C) or dexamethasone during the last 7 days of pregnancy. Results are expressed relative to the 18S ribosomal RNA
and are expressed as the mean + SEM. The number of adrenals in each group are shown on the columns. There were no statistically significant
differences. (B) Methylation of the three most proximal CpG sites in the Agtr1b promoter in the adrenal at 1 week of age. Each empty circle represents
an unmethylated CpG site, while filled circles represent methylated sites. Each column represents a single adrenal, the sex of which is shown above
the column. Each horizontal group of three circles indicates a single sequenced clone. The differences between the two groups were not statistically
significant.
doi:10.1371/journal.pone.0009237.g003
AT1b Programming
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Materials and Methods
Animals
The experiments described in this report were performed under
license from the Home Office in accordance with the 1986 Animals
(Scientific Procedures) Act. The study used rats of the Wistar strain,
and all animals were housed in plastic cages and subjected to a 12
hour light/dark cycle at a temperature of 20–22uC.
Metyrapone study. Twenty-four virgin female Wistar rats
(Harlan Ltd, Belton, Leics, UK) were mated at weights between
250 and 275 g. Upon confirmation of mating by the appearance of
a semen plug on the cage floor, the rats were allocated to be fed (ad
libitum) isoenergetic diets containing 18% protein (control, n = 8) or
9% protein (LP, n= 16), as described previously [27]. Half of the
LP fed rats received twice daily injections of metyrapone (5 mg/kg
body weight, in saline s.c group LPM) over days 1–14 of
pregnancy. Control rats and the remaining LP rats received
vehicle injections. Metyrapone was administered at a dose
previously shown to have no adverse effect upon reproductive
outcome and to reduce maternal corticosterone concentrations by
90% [29,44]. In unpublished work we have found that higher
doses led to fetal abnormalities. At delivery the litters were culled
to a maximum of eight pups (4 males and 4 females) to minimize
variation in suckling nutrition. Offspring were culled using CO2
asphyxia and cervical dislocation at 1 or 4 weeks of age (1 male
and 1 female per litter at each time point).
Dexamethasone study. Sixteen virgin female Wistar rats
(250–275g) were fed standard laboratory chow diet and were
mated with a stud male. At day 15 gestation the rats were
allocated for either vehicle injection (n = 8, 0.1 ml saline, s.c.
daily) or treatment with dexamethasone (n = 8, 100mg/kg body
weight daily, s.c. injection). As dexamethasone has been
reported to reduce food intake in rats, all vehicle-treated,
control animals were pair-fed to the dexamethasone group.
Treatment continued until the females gave birth on day 22 of
gestation. At delivery the litters were culled to a maximum of
eight pups (4 males and 4 females). Offspring were culled at 1
or 4 weeks of age (1 male and 1 female per litter) as previously.
These timepoints were selected as it is established that elevated
blood pressure is in place by 4 weeks [16] and the earlier
timepoint enabled evaluation of any adrenal changes ahead of
any influences of hypertension.
Blood Pressure Determination
Systolic blood pressure was determined using an IITC Model 229
Blood Pressure monitor as reported previously [16,23,25]. This tail-
cuff method has been extensively validated and refined to reduce
possible stress-related effects and observer subjectivity. Rats were
placed in a darkened room maintained at 27uC for 2 h and settled in
a Perspex tube. A suitably sized cuff was placed over the tail and
inflated to 300 mmHg. Pulses were recorded during deflation at a
rate of 3 mmHg/s. Blood pressure, which was determined in
triplicate for each animal, was derived using a preset algorithm via
appropriate software. The average systolic pressure from the three
measures was recorded. We have previously demonstrated that we
can acquire reproducible results without the need for training of the
animals to the procedure [23]. It has been demonstrated that values
obtained using this method are similar to those obtained under direct
anaesthesia [45]. Our earlier observations of raised tail-cuff pressures
in animals subject to prenatal protein restriction have been replicated
in studies using both radiotelemetry and swivel-cannulation systems
[46,47], as have studies which have focused upon antenatal
glucocorticoid administration to induce hypertension [48].Data
analysis included correction for body weight.
RNA Quantitation
Some of the offspring were culled at 7 days of age and total
RNA was isolated with Agencourt RNAadvance Tissue total RNA
purification kit (Agencourt, Beverley, MA, USA), which uses
paramagnetic bead-based technology in a 96-well format. Frozen
adrenals (2–10 mg) were homogenized (Precellys 24 benchtop
equipment, Montigny-le-Bretonneux, France). Half of the sample
was frozen for further DNA isolation and the remainder used for
RNA isolation. RNA was immobilized onto the paramagnetic
particles, treated with DNaseI (RNase-free, Ambion, Warrington,
UK)) and washed. Nucleic acid concentration was measured by a
Nanodrop ND1000 spectrophotometer.
cDNA was synthesized using MMLV reverse transcriptase
(Promega, Southampton, UK).
QPCR was performed using a 2-step cycling protocol:
95uC610 minutes, then 40 cycles of 95uC630 s and 59uC61
minute on the MX4000 (Stratagene, La Jolla, CA, USA). Primers
and probe were as described [22]. Amplification plots were
analyzed using MX4000 software version 3.0 (Stratagene). RNA
expression data were given as copy number of gene of interest/
18S RNA. Standards used were PCR fragments purified from a
polyacrylamide gel. All PCR reactions were performed in
triplicate.
Methylation Detection
Genomic DNA was isolated using the QIAamp DNA mini kit
(Qiagen, Crawley, UK). 0.5 mg DNA was subjected to bisulphite
treatment using EZ DNA Methylation-Gold Kit TM (ZYMO
Research, Orange, CA, USA) according to manufacturer’s
instructions. 4ml of DNA was used in PCR with primers designed
to the reverse strand bisulphite-converted DNA [22]. PCR
conditions were: 95uC610 minutes, then 40 cycles of
95uC630 s, 52uC61 minute, 72uC630 s and finally 1 cycle of 7
minutes 672uC. The reaction mixture contained 1x PCR Gold
buffer, 0.2 mmol/L dNTPs, 2 mmol/L MgCl2, 1 mmol/L primers
and 1.25U of AmpliTaq Gold DNA polymerase (Applied
Biosystems). Gel purified PCR products were passed through
SNAP columns (Invitrogen, Paisley, UK), cloned into pCR4-
TOPO vector (Invitrogen) and sequenced.
Statistical Analysis
All data was analysed using the Statistical Package for Social
Sciences (SPSS, Inc, Chicago, IL, Version 14.0). Differences
between groups were assessed using a mixed model ANOVA
(fixed factors, maternal treatment, age and offspring sex), unless
otherwise indicated in the text. A Bonferroni test was applied to
correct for multiple testing. Values are expressed as mean 6
S.E.M. P,0.05 was considered as significant. As multiple pups
from the same dam were used throughout this study, litter of
origin was included as a fixed nested factor in all analyses. The
frequency of cytosine methylation was compared using chi
squared analysis.
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